Funder
National Natural Science Foundation of China
State Key Laboratory Innovation Research and Cultivation Fund
“Double World-classes” Construction Program of China Pharmaceutical University
Publisher
Springer Science and Business Media LLC
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis
Reference30 articles.
1. Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L (2017) The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy. Int J Mol Med 402:271–280. https://doi.org/10.3892/ijmm.2017.3036
2. Zimmermann J (2009) Interview with Jürg Zimmermann, global head of oncology & exploratory chemistry at Novartis. Future Med Chem 18:1395–1398. https://doi.org/10.4155/Fmc.09.115
3. Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schiöth HB (2021) Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 2011:839–861. https://doi.org/10.1038/s41573-021-00252-y
4. Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D (2002) Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 810:3034–3038
5. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P (2008) Drug target identification using side-effect similarity. Science 3215886:263–266. https://doi.org/10.1126/science.1158140
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献